Evidence map›Paper›PMID 40645707›Full record

ArticleJACC. Case reports2025

Delayed Diagnoses of Cardiac Amyloidosis.

Cooper B Kersey, Graham Bevan, Douglas Leedy, Marta Alhama-Belotto, Babak Nazer, Kelly Smith, Ron Blankstein, Mathew S Mauer, Richard K Cheng

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in JACC. Case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Cooper B KerseyDepartment of Medicine, Division of Cardiology, University of Washington, Seattle, Washington, USA. Electronic address: kerseycb@uw.edu.
Graham BevanDepartment of Medicine, Division of Cardiology, University of Washington, Seattle, Washington, USA.
Douglas LeedyDepartment of Medicine, Division of Cardiology, University of Washington, Seattle, Washington, USA.
Marta Alhama-BelottoDepartment of Medicine, Division of Cardiology, University of Washington, Seattle, Washington, USA.
Babak NazerDepartment of Medicine, Division of Cardiology, University of Washington, Seattle, Washington, USA.
Kelly SmithDepartment of Pathology, University of Washington, Seattle, Washington, USA.
Ron BlanksteinDepartment of Medicine, Division of Cardiology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Mathew S MauerDepartment of Medicine, Division of Cardiology, Columbia University, New York, New York, USA.
Richard K ChengDepartment of Medicine, Division of Cardiology, University of Washington, Seattle, Washington, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cardiac sarcoidosis (CS) can be challenging to accurately diagnose and relies on a complex diagnostic framework because of the limited sensitivity of endomyocardial biopsy. Frequently, the diagnosis of CS depends on cardiac

Indexed as

cardiac amyloidosiscardiac sarcoidosiscase reportmultimodality imagingnonischemic cardiomyopathy

Identifiers

PMID40645707
PMCPMC12441432

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.